MD Anderson Events

Use of Vemerafenib in Metastatic Melanoma

• Review common targeted therapy treatment of metastatic melanoma
• Identify pathology findings that indicate a patient is a candidate for BRAF inhibitors
• Identify patients characteristics that indicate use of BRAF inhibitors
• State toxicities of BRAF inhibitors and associated nursing interventions
• Discuss how BRAF is used in combinations therapies

Date: 3/26/13, 1:30pm to 2:30pm
Time: 3/26/13, 1:30pm to 2:30pm
Location: P10 Conference Room
Format: Training/Employee Development
CME: Contact Hours: 1.0
Speaker: Tina Dett, FNP
Contact: Cindy Murphy - 39297 - cmurphy@mdanderson.org

Add event to my calendar